We report on three cases wherein treatment of dexmedetomidine-induced bradycardia with i.v. glycopyrrolate (5.0 microg/kg) not only resulting in resolution of bradycardia but also resulting in an exaggerated increase of arterial blood pressure.
bradycardia
dexmedetomidine
exaggerated increase of arterial blood pressure
glycopyrrolate